Intrastromal Injections in the Management of Infectious Keratitis.
Mihail Zemba, Madalina Radu, Sinziana Istrate...
https://pubmed.ncbi.nlm.nih.gov/37111577/Actively Recruiting
Led by Minia University · Updated on 2026-09-10
60
Participants Needed
1
Research Sites
26 weeks
Total Duration
This research aims to evaluate the use of intrastromal moxifloxacin injection as an additional treatment for patients with recalcitrant bacterial keratitis, a serious corneal infection that can threaten sight and often does not respond well to standard intensive topical antibiotics. The study compares the safety and effectiveness of adding intrastromal moxifloxacin to standard topical therapy versus standard therapy alone. The goal is to understand if this targeted delivery can improve outcomes by reaching deeper corneal layers. Participants will receive either an intrastromal injection of preservative-free moxifloxacin 0.5% using a fine needle alongside intensive topical moxifloxacin eye drops every 1-2 hours initially, or they will receive the standard intensive topical moxifloxacin therapy alone. Dosing of eye drops will be tapered according to clinical response. The study follows a randomized, parallel design with quadruple masking. Throughout the study, participants will be assessed weekly until complete healing, measuring the time to full clinical resolution of infection as the primary outcome. Secondary outcomes include epithelial defect size, hypopyon height, pain score, visual acuity, and possible complications such as perforation or endophthalmitis. Monitoring will continue for up to three months to evaluate safety and healing progress, with the total study duration extending to October 2026.
CONDITIONS
Intrastromal Moxifloxacin as an Adjunctive Therapy in Recalcitrant Bacterial Keratitis
M
Mahmoud Ramadan Amer, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Minia University
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 1 month
Participants receive either an intrastromal injection of moxifloxacin plus intensive topical eye drops or intensive topical eye drops alone, with dosing tapered according to clinical response.
Weekly visits
Duration - Up to 3 months
Participants are monitored for healing progress, visual acuity improvement, and any treatment-related complications.
Periodic visits as needed
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Mihail Zemba, Madalina Radu, Sinziana Istrate...
https://pubmed.ncbi.nlm.nih.gov/37111577/Minia University
Lead Sponsor